JCMVX | VEVYX | JCMVX / VEVYX | |
Total Expense Ratio | 1.59 | 0.66 | 241% |
Annual Report Gross Expense Ratio | 1.70 | 0.66 | 258% |
Fund Existence | 24 years | 12 years | - |
Gain YTD | -12.761 | -14.165 | 90% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 1000000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 11.2B | 16.5B | 68% |
Annual Yield % from dividends | 0.15 | 1.12 | 13% |
Returns for 1 year | -17.62 | -20.22 | 87% |
Returns for 3 years | -23.06 | -16.41 | 141% |
Returns for 5 years | 2.59 | 35.80 | 7% |
Returns for 10 years | -20.28 | 25.08 | -81% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
FDTX | 31.19 | 3.33 | +11.95% |
Fidelity Disruptive Technology ETF | |||
UBR | 15.93 | 1.62 | +11.33% |
ProShares Ultra MSCI Brazil Capped | |||
BIB | 40.66 | 3.67 | +9.92% |
ProShares Ultra Nasdaq Biotechnology | |||
IYJ | 125.11 | 10.04 | +8.73% |
iShares US Industrials ETF | |||
XSHQ | 37.09 | 2.75 | +8.01% |
Invesco S&P SmallCap Quality ETF |